These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22893256)

  • 61. Comparison of metoprolol tartrate multiple-unit lipid matrix systems produced by different technologies.
    Aleksovski A; Van Bockstal PJ; Roškar R; Sovány T; Regdon G; De Beer T; Vervaet C; Dreu R
    Eur J Pharm Sci; 2016 Jun; 88():233-45. PubMed ID: 26980237
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying.
    Hu J; Ng WK; Dong Y; Shen S; Tan RB
    Int J Pharm; 2011 Feb; 404(1-2):198-204. PubMed ID: 21056643
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Sucrose esters with various hydrophilic-lipophilic properties: novel controlled release agents for oral drug delivery matrix tablets prepared by direct compaction.
    Chansanroj K; Betz G
    Acta Biomater; 2010 Aug; 6(8):3101-9. PubMed ID: 20132913
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Solutions as solutions--synthesis and use of a liquid polyester excipient to dissolve lipophilic drugs and formulate sustained-release parenterals.
    Asmus LR; Gurny R; Möller M
    Eur J Pharm Biopharm; 2011 Nov; 79(3):584-91. PubMed ID: 21820511
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Preparation, characterization and application of chitosan-alginate based polyelectrolyte complex as fast disintegrating drug delivery carrier.
    Malviya R; Srivastava P
    Polim Med; 2011; 41(3):45-54. PubMed ID: 22046827
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A review on the taste masking of bitter APIs: hot-melt extrusion (HME) evaluation.
    Maniruzzaman M; Boateng JS; Chowdhry BZ; Snowden MJ; Douroumis D
    Drug Dev Ind Pharm; 2014 Feb; 40(2):145-56. PubMed ID: 23763436
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Microstructural effects in drug release by solid and cellular polymeric dosage forms: A comparative study.
    Blaesi AH; Saka N
    Mater Sci Eng C Mater Biol Appl; 2017 Nov; 80():715-727. PubMed ID: 28866221
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Interpolymer complexes of carbopol® 971 and poly(2-ethyl-2-oxazoline): Physicochemical studies of complexation and formulations for oral drug delivery.
    Moustafine RI; Viktorova AS; Khutoryanskiy VV
    Int J Pharm; 2019 Mar; 558():53-62. PubMed ID: 30634031
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The influence of formulation factors on the kinetic release of metoprolol tartrate from prolong release coated minitablets.
    Tomuta I; Leucuta SE
    Drug Dev Ind Pharm; 2007 Oct; 33(10):1070-7. PubMed ID: 17852365
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Mechanochemical Synthesis of Pharmaceutical Cocrystal Suspensions via Hot Melt Extrusion: Feasibility Studies and Physicochemical Characterization.
    Li S; Yu T; Tian Y; McCoy CP; Jones DS; Andrews GP
    Mol Pharm; 2016 Sep; 13(9):3054-68. PubMed ID: 27314248
    [TBL] [Abstract][Full Text] [Related]  

  • 72. 3D-micro-patterned fibrous dosage forms for immediate drug release.
    Blaesi AH; Saka N
    Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():218-229. PubMed ID: 29519432
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Advances in solid dosage form manufacturing technology.
    Andrews GP
    Philos Trans A Math Phys Eng Sci; 2007 Dec; 365(1861):2935-49. PubMed ID: 17855217
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A Biodegradable Copolyester, Poly(butylene succinate-
    Galdón E; Millán-Jiménez M; Mora-Castaño G; de Ilarduya AM; Caraballo I
    Pharmaceutics; 2021 Jul; 13(7):. PubMed ID: 34371748
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Shielding of Hepatitis B Virus-Like Nanoparticle with Poly(2-Ethyl-2-Oxazoline).
    Fam SY; Chee CF; Yong CY; Ho KL; Mariatulqabtiah AR; Lau HY; Tan WS
    Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31623310
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Sweet Polymers: Poly(2-ethyl-2-oxazoline) Glycopolymers by Reductive Amination.
    Mees MA; Effenberg C; Appelhans D; Hoogenboom R
    Biomacromolecules; 2016 Dec; 17(12):4027-4036. PubMed ID: 27768273
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Poly(2-methyl-2-oxazoline) conjugates with doxorubicin: From synthesis of high drug loading water-soluble constructs to in vitro anti-cancer properties.
    Sedlacek O; Van Driessche A; Uvyn A; De Geest BG; Hoogenboom R
    J Control Release; 2020 Oct; 326():53-62. PubMed ID: 32565042
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Micro-Scale Vacuum Compression Molding as a Predictive Screening Tool of Protein Integrity for Potential Hot-Melt Extrusion Processes.
    Dauer K; Wagner KG
    Pharmaceutics; 2023 Feb; 15(3):. PubMed ID: 36986585
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Formulation of Carbopol
    Ruiz-Rubio L; Alonso ML; Pérez-Álvarez L; Alonso RM; Vilas JL; Khutoryanskiy VV
    Polymers (Basel); 2018 Feb; 10(2):. PubMed ID: 30966211
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Study of formulation parameters by factorial design in metoprolol tartrate matrix systems.
    Miñarro M; García-Montoya E; Suñé-Negre JM; Ticó JR
    Drug Dev Ind Pharm; 2001 Oct; 27(9):965-73. PubMed ID: 11763475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.